When transplanting before transformation to MDS, non-myeloablative regimens similar to the ones used for Fanconi’s anemia or GATA2 deficiency syndrome can probably be used [33, 34], even though evidence for this assumption are missing at the moment. Here, GATA2 is linked to Fanconi anemia.